Chronic Kidney Disease(CKD 5D)
Conditions
Interventions
experimental group:hydrotalcite
Control group:aluminium hydroxide
Sponsors
Xiamen Zhongshan Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1. Patient who were maintained hemodialysis over 3 months; 2. aged between 18-80 years old; 3. male or female; 4. serum phosphorus >1.78mmol/L; 5. Didn't given any treatment of reducing phosphorus, including aluminium hydroxide, hydrotalcite and lanthanum carbonate; 6. Signed a letter of authorization for patients, allowing the use and disclosure of personal health information (or informed consent, if applicable).
Exclusion criteria
Exclusion criteria: 1. Patients of maintain hemodialysis less than 3 months; 2. Age less than 18 and over 80 years old; 3. Serum phosphorus <1.78mmol/L; 4. Have given any treatment of reducing phosphorus in 3 months, including aluminium hydroxide,hydrotalcite and lanthanum carbonate; 5. The patients whose refuse taking part in the trial; 6. Patients combined with tumour, active bleeding, infection and other acute inflammation; 7. Patients who maybe renal transplant or peritoneal dialysis or go to other hospital in half year; 8. Patients who die during trial.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| serum phosphorum;Serum aluminium; | — |
Secondary
| Measure | Time frame |
|---|---|
| serum calcium;Serum parathyroid hormone ; | — |
Countries
China
Contacts
Public ContactGuan Tianjun
Outcome results
None listed